| European Case Law Identifier: | ECLI:EP:BA:2005:T058301.20050726 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 26 July 2005 | ||||||||
| Case number: | T 0583/01 | ||||||||
| Application number: | 93203476.2 | ||||||||
| IPC class: | A61K 9/16 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Pharmaceutical granulate containing steroids | ||||||||
| Applicant name: | Akzo Nobel N.V. | ||||||||
| Opponent name: | Grünenthal GmbH Hexal AG Durascan Medical Products A/S Biogaran |
||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Admissibility of the requests filed during the oral proceedings (no): Amendments generating a new framework of discussion at such a late stage Novelty of the products claimed (no): Tablets and granules lack novelty vis-Ã -vis the prior art Novelty of the process claimed (yes): The prior art does not disclose directly and unambiguosly all process features Inventive step of the process claimed (no): Analogous process |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t010583eu1.html
Date retrieved: 17 May 2021